PROSPECTUS SUPPLEMENT File No. 333-80813
Filed Pursuant to Rule 424(b)(2)
Under the Securities Act of 1933
PHARMOS CORPORATION
1,000,000 Shares of Common Stock
This prospectus may be used only in connection with the sale of 1,000,000
shares of common stock, par value $.03 per share, of Pharmos Corporation, a
Nevada corporation, to Amro International, S.A., a Panama corporation, at a
price of $2.3906 per share (an aggregate purchase price of $2,390,600).
Pharmos's common stock is traded on the over-the-counter market and is
quoted on the Nasdaq SmallCap Market under the symbol "PARS." The closing price
of the common stock on January 31, 2000 was $2.9375.
USE OF PROCEEDS
The proceeds to Pharmos from the sale of shares covered by this prospectus
supplement will be $2,390,600. Pharmos will use these proceeds primarily for
research and product development activities, conducting preclinical studies and
clinical trials, and purchasing equipment.
PLAN OF DISTRIBUTION
The transaction covered by this prospectus supplement is the sale of
1,000,000 shares of Pharmos common stock to Amro International, S.A., based upon
a Subscription Agreement dated February 3, 2000. Amro International, S.A., has
represented in the Subscription Agreement that it is purchasing the Pharmos
shares as principal for its own account and has no present arrangements or
obligations to sell any of the shares to any other person. Pharmos has not
engaged any underwriter or placement agent in connection with this sale.
The date of this prospectus supplement is February 8, 2000.
